Question

Biotechnology patents have diluted the patenting norms. Comment

18 Apr 2025
Answer :
Word Count : 687

Biotechnology patents have played a significant role in the evolution of intellectual property law, especially as the biotechnological industry has grown exponentially over the past few decades. However, the increasing number of biotechnology patents has led to debates surrounding the dilution of traditional patenting norms, which were originally designed to protect tangible inventions. The core issue revolves around the balance between incentivizing innovation and safeguarding public interest, particularly in the context of life sciences and genetic material.

One of the primary concerns with biotechnology patents is that they extend patent protection to products that involve naturally occurring biological elements, such as genes, proteins, and even entire organisms. These are concepts that traditionally may not have been eligible for patents because they are found in nature. The emergence of patents in biotechnology, including genetic modifications and isolated natural substances, has raised significant ethical and legal questions. For example, the patenting of human genes by companies such as Myriad Genetics in the United States, which patented the BRCA1 and BRCA2 genes related to breast cancer, sparked a major debate. Critics argue that patents on such genetic material are harmful because they could limit access to essential medical tests and treatments for individuals, and undermine the right to free access to basic human biology.

Internationally, the protection of biotechnology inventions has been governed by frameworks such as the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which sets minimum standards for patent protection. TRIPS allows countries to grant patents

______ __________ __________ ____ __________ ________ ________ ________ ________.
_____ __________ __________ _____ _____ _____ _____ _____ ________ _____ _____.
_____ _______ ____ ________ __________ _______ _________ ____.
__________ ______ _________ ______ _________ ________ ________ ____ ________ __________ ___.
________ ________ _____ _________ _______.
____ _________ ________ ________ _______ _____ ___ ____ ___ _____ ___ ________.
__________ ______ _________ _______ ______ ________ ______ ________ ______ _________ _________.
____ _____ ________ _______ ________ ________ ___ _________ _____.
__________ _____ ____ ___ ______ _______ _____ ___ ________ ___.
___ ___ _____ _______ ______.
_________ ___ _____ _________ __________ ______ ____ _________ ___ ___ ________ ____.
________ __________ ____ _____ _____ _______.
_______ ________ ___ ________ ____ _______ ______.
____ _________ _________ ______ _____ _________ ___ _____ __________.
______ _______ ______ _________ ___ ______ _________ ________ ____.
______ _______ __________ ________ ___ _____ ______.
_____ ______ ________ ____ __________ _____ _____ ____ ____.
_____ _______ ___ ___ __________ _____.
________ _____ ______ _____ _______.
__________ ___ __________ ________ _________.
_____ ____ _______ _________ ________ ______ ____.
____ _____ ______ ____ ___ ____ _________ _____ ________ ________ _______.
__________ _________ _____ _______ _______ __________ ___.
_________ _______ ________ _______ _________ __________ _______.
_________ ____ _____ _________ _________ ________ ____ ______ ___ _____ _______ ____.
______ ________ ___ ____ ___ ____ ________ _______ __________ _________ ____.
_________ ________ _______ __________ _________ _______ ________ _______.
__________ _____ ____ ______ ________.
______ _________ _____ ____ _____ ___ ________ ____ __________ ______ ___.
__________ _______ ___ ________ _______ ________ ______ ______ _________ ______.
________ _________ _______ __________ _________ ________ ____ ______.
____ ______ _________ _______ ____.
_________ _________ ___ ____ _______ __________.
______ ___ _________ __________ ___ ____ ___ _______.
______ ________ ___ _____ _____ ________ __________ _____ _________ ____ ______.
___ __________ ____ _____ _______ __________.
_________ _________ _____ ____ _________ ____ _____ __________ ________.
_______ ___ _______ __________ ____ _____ _________.
___ ___ _______ ____ __________ _________ ___ ____ ______ _______ _________.
__________ ________ __________ _____ ________ ___ ______ ___ ________ __________.
_________ _______ ______ ___ ____ _________ _________.
________ ______ ________ __________ ___ __________ _________ __________ _____ __________ _______.
_______ __________ _____ __________ _______ _________ _________ ______ _________ _____ _______ ____.
______ ____ ________ _____ _______ _____ ___ ________.
_____ _________ _____ _______ ________ _________ _________ ____ ________ ___ ________.
_____ ____ _____ _________ ______ _________ _______ ____ __________ ____.
_______ _____ ________ ____ _________ _______ ________ _____ ________ _________.
______ ____ __________ _____ __________ ________ ______.
_________ ______ ________ __________ _____ ____ _______ ___ _____.
________ ___ _____ _____ __________ ______.
_________ ______ ___ ____ _____ _____ ______ _________.
_________ ____ ________ ____ _______.
IGNOU ACADEMY
Your IGNOU journey, made easier.
  • Solved Assignments
  • Study Notes
  • Guess Papers
  • Question Papers
Skip in 10
Top
📞
Call Support Instant phone assistance IGNOU MIR 22 2025 - Biotechnology patents have diluted the patenting norms. Comment | IGNOU Academy
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→